| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024217166 |
| P356 | DOI | 10.1007/S12026-007-0022-2 |
| P698 | PubMed publication ID | 17917016 |
| P50 | author | Hans D. Ochs | Q115437 |
| Troy R Torgerson | Q96130732 | ||
| Eleonora Gambineri | Q43300293 | ||
| P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
| Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation | Q24291515 | ||
| FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 | ||
| Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells | Q24298812 | ||
| Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor | Q24300325 | ||
| Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells | Q24306205 | ||
| X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. | Q24539046 | ||
| JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome | Q24626901 | ||
| Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation | Q56941507 | ||
| A new case of IPEX receiving bone marrow transplantation | Q58800451 | ||
| Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level | Q60311694 | ||
| Could protracted diarrhoea of infancy have an autoimmune pathogenesis? | Q72526144 | ||
| Congenital autoimmune diabetes mellitus | Q73810945 | ||
| A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy | Q74404652 | ||
| A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome | Q77091536 | ||
| Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells | Q81577003 | ||
| Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome | Q24679039 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| The amount of scurfin protein determines peripheral T cell number and responsiveness | Q28504592 | ||
| Winged helix proteins | Q29617630 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| Forkhead transcription factors: key players in development and metabolism | Q29618804 | ||
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
| The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
| Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome | Q30305447 | ||
| Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature | Q30440761 | ||
| Identification of an autoimmune enteropathy-related 75-kilodalton antigen | Q30779073 | ||
| Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome. | Q33336778 | ||
| Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome | Q33360497 | ||
| Immunologic self tolerance maintained by T-cell-mediated control of self-reactive T cells: implications for autoimmunity and tumor immunity | Q34374572 | ||
| Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis | Q35159540 | ||
| Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease | Q35848361 | ||
| A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. | Q36078042 | ||
| CD4+ regulatory T cells: mechanisms of induction and effector function. | Q36281207 | ||
| Cd4+Cd25+ regulatory T cells and their therapeutic potential | Q36366885 | ||
| Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma | Q40436418 | ||
| Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells | Q40498116 | ||
| Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen | Q40701079 | ||
| Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. | Q44509623 | ||
| In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity | Q45884432 | ||
| Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine | Q46508260 | ||
| Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer | Q46549031 | ||
| Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). | Q46673023 | ||
| Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells | Q47339163 | ||
| Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. | Q51993610 | ||
| Functional CD25– and CD25+ mucosal regulatory T cells are induced in gut‐draining lymphoid tissue within 48 h after oral antigen application | Q52005392 | ||
| Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. | Q52573741 | ||
| An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. | Q55062928 | ||
| Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen | Q56902816 | ||
| Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells | Q56903036 | ||
| Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells | Q56903547 | ||
| Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration | Q56904883 | ||
| P433 | issue | 1-3 | |
| P304 | page(s) | 112-121 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity | |
| P478 | volume | 38 |
| Q89186695 | A clinically applicable adjuvant for an atherosclerosis vaccine in mice |
| Q35101760 | Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis |
| Q51142501 | Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases. |
| Q33423983 | Association of CD4(+)CD25(+)FoxP3(+) regulatory T cells with natural course of childhood chronic immune thrombocytopenic purpura |
| Q37158241 | Autoantibodies in scurfy mice and IPEX patients recognize keratin 14. |
| Q33811669 | Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis |
| Q33394794 | Autoimmunity in primary immune deficiency: taking lessons from our patients |
| Q36736307 | Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17. |
| Q34627919 | CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model |
| Q35178495 | CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game |
| Q39295075 | CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer |
| Q33420692 | Circulating regulatory T cells in patients with severe fever with thrombocytopenia syndrome |
| Q34440616 | Clues to immune tolerance: the monogenic autoimmune syndromes |
| Q33945522 | Common variants in FOXP1 are associated with generalized vitiligo. |
| Q35859565 | Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome. |
| Q40169924 | Depletion of FoxP3(+) Tregs improves control of larval Echinococcus multilocularis infection by promoting co-stimulation and Th1/17 immunity |
| Q36901678 | Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome |
| Q38161794 | Emerging cell and cytokine targets in rheumatoid arthritis |
| Q85640640 | Enteropathies of infancy and childhood |
| Q93090571 | Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells |
| Q37644295 | Evolving paradigms in the pathogenesis of IBD. |
| Q42655696 | Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy |
| Q37972689 | Foxp3(+) regulatory T cells, immune stimulation and host defence against infection |
| Q35646681 | Gene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome. |
| Q89802131 | Genetics of type 1 diabetes |
| Q42241730 | Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2 |
| Q37699956 | Immunodeficiency due to mutations in ORAI1 and STIM1. |
| Q26772723 | Inducing and Administering Tregs to Treat Human Disease |
| Q37848684 | Inhibition of histone deacetylases in inflammatory bowel diseases |
| Q26864276 | Innate and adaptive immunity in inflammatory bowel disease |
| Q46113188 | Insights into immune tolerance from AIRE deficiency |
| Q27006792 | Insights into type 1 diabetes from the autoimmune polyendocrine syndromes |
| Q27008200 | Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity |
| Q34615216 | Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases |
| Q33962548 | Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis |
| Q38175191 | Modern management of primary T-cell immunodeficiencies. |
| Q37973770 | Monogenic autoimmunity |
| Q39440937 | Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD. |
| Q36385626 | Occupational exposure to formaldehyde and alterations in lymphocyte subsets |
| Q48128144 | Patients with pediatric obstructive sleep apnea show altered T-cell populations with a dominant TH17 profile |
| Q54329786 | Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease? |
| Q56892402 | Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects |
| Q51543975 | Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. |
| Q34832611 | Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies |
| Q33384395 | STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity |
| Q59136361 | Serum microRNA Profiles Serve as Novel Biomarkers for Autoimmune Diseases |
| Q27667400 | Structure of a Domain-Swapped FOXP3 Dimer on DNA and Its Function in Regulatory T Cells |
| Q39413297 | Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells |
| Q40789090 | Systemic T Cells and Monocyte Characteristics in Patients with Denture Stomatitis. |
| Q37813401 | T-cell alloimmunity and chronic allograft dysfunction |
| Q45054246 | T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata |
| Q34161509 | The Ets-1 transcription factor controls the development and function of natural regulatory T cells. |
| Q37864831 | The dual role of the X-linked FoxP3 gene in human cancers |
| Q36000638 | The forkhead transcription factor, FOXP3, is required for normal pituitary gonadotropin expression in mice |
| Q34009654 | The power and the promise of restimulation-induced cell death in human immune diseases |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q41247751 | Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy |
| Q36964828 | Update in endocrine autoimmunity |
| Q28081150 | Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease |
| Q27014906 | Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease |
| Q39262694 | YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α. |
Search more.